Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00634998 · ClinicalTrials.gov registry record · Phase 1
Vitamin C Supplementation as a Preventive Treatment of Diabetic Peripheral Neuropathy
A Phase 1 study of Diabetic Neuropathies, sponsored by Washington State University.
- Completed
- Registry status
- Phase 1
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT00634998 is a Phase 1 study of Diabetic Neuropathies that has completed, run by Washington State University. The registered enrollment target is 10 participants, below the 327-participant average among 8 other Diabetic Neuropathies trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00634998, a Phase 1 study of Diabetic Neuropathies, has completed, sponsored by Washington State University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this pilot study is to determine whether vitamin C supplementation is beneficial in treating and/or preventing diabetic peripheral neuropathy in people with type 2 diabetes.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Vitamin C
Study Locations (1)
Washington
- Washington State University, College of Pharmacy, Department of Pharmacotherapy - Spokane
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2007-11 |
| Est. Completion | 2008-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00634998
The ClinicalTrials.gov registry entry for NCT00634998 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 327-participant average among 8 other Diabetic Neuropathies trials with a reported enrollment target (97% lower). The listed sponsor is Washington State University, which has 64 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Diabetic Neuropathies appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT00634998 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.
Frequently Asked Questions
What is clinical trial NCT00634998 about?
NCT00634998 is a clinical study titled "Vitamin C Supplementation as a Preventive Treatment of Diabetic Peripheral Neuropathy". The purpose of this pilot study is to determine whether vitamin C supplementation is beneficial in treating and/or preventing diabetic peripheral neuropathy in people with type 2 diabetes.
What is the current status of trial NCT00634998?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2007-11. Estimated completion is 2008-08.
What conditions does trial NCT00634998 study?
This clinical trial studies the following conditions: Diabetic Neuropathies.
What interventions are being tested in trial NCT00634998?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Vitamin C (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00634998?
This trial is sponsored by Washington State University, which has 64 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00634998 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetic Neuropathies
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Omega-3 Fatty Acid Lipidomics in Diabetes Peripheral Neuropathy
RECRUITING · Phase 1
-
Optimization of NIBS for Diabetic Neuropathy Neuropathic Pain
ACTIVE NOT RECRUITING · NA
-
Thermal Screening for Early Diabetic Peripheral Neuropathy (DPN)
COMPLETED
-
Efficacy and Safety of TAK-583 in Subjects With Diabetic Peripheral Neuropathy
COMPLETED · Phase 2
-
Treatment of Peripheral Neuropathy in Patients With Diabetes
COMPLETED · Phase 3
-
Cebranopadol Efficacy and Safety in Diabetic Patients Suffering From Chronic Pain Caused by Damage to the Nerves
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.